Prener Anne Insider Profile
4 Followers
Prener Anne, Director at Keros Therapeutics, holds 13.79K shares in Keros Therapeutics (Ticker: KROS), holds ― shares in Kaleido Biosciences (Ticker: KLDO), holds ― shares in Damora Therapeutics (Ticker: DMRA).
Prener Anne has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Prener Anne holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Prener Anne
Prener Anne's Trading History
Keros Therapeutics
Jul 06, 2026
Director
Uninformative Buy
―
$153.99K
Kaleido Biosciences
―
Director
―
―
Damora Therapeutics
―
Director
―
―
Rubius Therapeutics
―
―
―
―
List of latest transactions for each holding click on a transaction to see Prener Anne's performance on stock
You May Also Like
Prener Anne insider profile FAQ
What is the percentage of profitable transactions made by Prener Anne?
The percentage of profitable transactions made by Prener Anne is ―.
What is the average return per transaction made by Prener Anne?
The average return per transaction made by Prener Anne is ―.
What stocks does Prener Anne hold?
Prener Anne holds: KROS, KLDO, DMRA, RUBY stocks.
What was Prener Anne’s latest transaction?
Prener Anne latest transaction was an Uninformative Buy of ―.
What was Prener Anne's most profitable transaction?
Prener Anne’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Prener Anne's role in Keros Therapeutics?
Prener Anne's role in Keros Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.